These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27767087)

  • 1. Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction.
    Rojas LA; Moreno R; Calderón H; Alemany R
    Cancer Gene Ther; 2016 Dec; 23(12):411-414. PubMed ID: 27767087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.
    Carlisle RC; Di Y; Cerny AM; Sonnen AF; Sim RB; Green NK; Subr V; Ulbrich K; Gilbert RJ; Fisher KD; Finberg RW; Seymour LW
    Blood; 2009 Feb; 113(9):1909-18. PubMed ID: 19131551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Surface Integrins and CAR Are Both Essential for Adenovirus Type 5 Transduction of Canine Cells of Lymphocytic Origin.
    Agarwal P; Gammon EA; Sajib AM; Sandey M; Smith BF
    PLoS One; 2017; 12(1):e0169532. PubMed ID: 28068367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.
    Takagi-Kimura M; Yamano T; Tamamoto A; Okamura N; Okamura H; Hashimoto-Tamaoki T; Tagawa M; Kasahara N; Kubo S
    Cancer Sci; 2013 Nov; 104(11):1433-9. PubMed ID: 23962292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5.
    Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR
    Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.
    Uusi-Kerttula H; Davies J; Coughlan L; Hulin-Curtis S; Jones R; Hanna L; Chester JD; Parker AL
    Oncotarget; 2016 May; 7(19):27926-37. PubMed ID: 27056886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.
    Granio O; Porcherot M; Corjon S; Kitidee K; Henning P; Eljaafari A; Cimarelli A; Lindholm L; Miossec P; Boulanger P; Hong SS
    J Virol; 2009 Jun; 83(12):6048-66. PubMed ID: 19357170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.
    Yun CO; Yoon AR; Yoo JY; Kim H; Kim M; Ha T; Kim GE; Kim H; Kim JH
    Hum Gene Ther; 2005 Feb; 16(2):248-61. PubMed ID: 15761264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
    Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.
    Ingemarsdotter CK; Tookman LA; Browne A; Pirlo K; Cutts R; Chelela C; Khurrum KF; Leung EY; Dowson S; Webber L; Khan I; Ennis D; Syed N; Crook TR; Brenton JD; Lockley M; McNeish IA
    Mol Oncol; 2015 Apr; 9(4):791-805. PubMed ID: 25560085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes.
    Zafar S; Quixabeira DCA; Kudling TV; Cervera-Carrascon V; Santos JM; Grönberg-Vähä-Koskela S; Zhao F; Aronen P; Heiniö C; Havunen R; Sorsa S; Kanerva A; Hemminki A
    Cancer Gene Ther; 2021 May; 28(5):442-454. PubMed ID: 32920593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
    Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
    J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus vectors composed of subgroup B adenoviruses.
    Sakurai F; Kawabata K; Mizuguchi H
    Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
    Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Intracellular Domain of the Coxsackievirus and Adenovirus Receptor Differentially Influences Adenovirus Entry.
    Loustalot F; Kremer EJ; Salinas S
    J Virol; 2015 Sep; 89(18):9417-26. PubMed ID: 26136571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.
    Lee CH; Kasala D; Na Y; Lee MS; Kim SW; Jeong JH; Yun CO
    Biomaterials; 2014 Jul; 35(21):5505-16. PubMed ID: 24731708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5.
    Waddington SN; Parker AL; Havenga M; Nicklin SA; Buckley SM; McVey JH; Baker AH
    J Virol; 2007 Sep; 81(17):9568-71. PubMed ID: 17553882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.
    Lewis TB; Glasgow JN; Glandon AM; Curiel DT; Standaert DG
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.